Our partner is focused on developing innovative cancer therapies, particularly through immune-based treatments. They aim to enhance the body’s immune response to fight tumors, addressing unmet needs in oncology and improving patient outcomes with targeted therapies.

This critical hire provided strategic and technical leadership for the optimization and administration of a complete Quality Program. They oversaw all GCP, GMP, and GLP (GXP) Quality Assurance functions, in compliance with FDA, European and other country-specific regulations. They also developed collaborative and productive partnerships internally as well as externally with contract research/manufacturing organizations.